[1]杨 英,吴 翔,张文华,等.川芎嗪通过调控组蛋白乙酰化修饰上调SERCA2a对心力衰竭小鼠模型的防治机制研究[J].现代检验医学杂志,2021,36(06):34-40.[doi:10.3969/j.issn.1671-7414.2021.06.007]
 YANG Ying,WU Xiang,ZHANG Wen-hua,et al.Research on Prevention and Control Mechanism of the Ligustrazine Up Regulates SERCA2a by Regulating Histone Acetylation in A Mouse Model of Heart Failure[J].Journal of Modern Laboratory Medicine,2021,36(06):34-40.[doi:10.3969/j.issn.1671-7414.2021.06.007]
点击复制

川芎嗪通过调控组蛋白乙酰化修饰上调SERCA2a对心力衰竭小鼠模型的防治机制研究()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第36卷
期数:
2021年06期
页码:
34-40
栏目:
论 著
出版日期:
2021-12-15

文章信息/Info

Title:
Research on Prevention and Control Mechanism of the Ligustrazine Up Regulates SERCA2a by Regulating Histone Acetylation in A Mouse Model of Heart Failure
文章编号:
1671-7414(2021)06-034-07
作者:
杨 英吴 翔张文华
(1.陕西省第四人民医院重症医学科 ,西安 710043; 2.西安交通大学医学院基础医学院,西安 710012)
Author(s):
YANG Ying WU Xiang ZHANG Wen-hua et al
(1.Department of Critical Medicine, the Fourth People’s Hospital of Shaanxi , Xi’an 710043,China;2. School of Basic Medicine, School of Medicine, Xi’an Jiaotong University,Xi’an 710012, China)
关键词:
川芎嗪组蛋白乙酰化心肌肌浆网Ca2+-ATPase 2a心力衰竭
分类号:
R-332;
DOI:
10.3969/j.issn.1671-7414.2021.06.007
文献标志码:
A
摘要:
目的 研究川芎嗪(ligustrazine, LGSZ)是否通过调控组蛋白乙酰化修饰上调心肌肌浆网Ca2+-ATPase 2a(SERCA2a)在预防心力衰竭中发挥作用。方法 通过微创性横向主动脉缩窄(TAC)手术构建心力衰竭的小鼠模型,超声心动图评价LGSZ干预后心脏功能变化,实时定量聚合酶链式反应(qPCR),western blot及ChIp检测SERCA2a相关蛋白和基因表达,并通过试剂盒检测组蛋白去乙酰化酶1(HDAC1)活性。结果 TAC+LGSZ组手术前后左心室前壁舒张末期厚度(LVAWd)、舒张末期左室后壁厚度(LVPWd)、射血分数(EF)及缩短分数(FS)比较,差异均无统计学意义(t=0.245~1.054,均P>0.05)。TAC+LGSZ组SERCA2a mRNA和SERCA2a蛋白表达显著高于TAC组,差异有统计学意义(t=4.817,3.913,均P<0.001)。TAC+LGSZ组中总AcH3和AcH3K9与SHAM组比较,差异无统计学意义(t=0.624,1.249, 均P>0.05)。TAC组HDAC1酶活性和HDAC1水平均高于SHAM组和TAC+LGSZ组,差异均有统计学意义(t=2.361~4.309,均P<0.05)。TAC组心脏组织中,Atp2a2启动子区域附近GATA4和Mef2c水平低于TAC+LGSZ组,差异有统计学意义(t=4.816,5.007,均P<0.001)。结论 LGSZ通过调控组蛋白乙酰化修饰上调SERCA2a在压力超负荷引起的心力衰竭中起预防作用。
Abstract:
Objective To study the ligustrazine (LGSZ) whether upregulates sarcoplasmic reticulum Ca2+-ATPase (SERCA2a) by regulating histone acetylation to play a role in preventing heart failure. Methods  Minimally invasive transverse aortic constriction (TAC) surgery was used to construct a mouse model of heart failure. Echocardiography was used to evaluate the change of cardiac function after LGSZ intervention.The real time quantitative polymerase chain reaction (qPCR), Western blot and ChIp were used to detect the expression of SERCA2a related protein and gene, and the HDAC1 activity was detected by kit. Results  There were no significant difference in left ventricular posterior wall thickness(LVAWd), left ventricular posterior wall thickness (LVPWd), ejection fraction (EF) and fractional shortening (FS) before and after operation in TAC + LGSZ group (t=0.245, 1.054, all P>0.05).The expression of SERCA2a mRNA and protein in TAC+LGSZ group were significantly higher than those in TAC group (t=4.817, 3.913, all P<0.001).There were no significant difference in total AcH3 and AcH3k9 between TAC+LGSZ group and SHAM group (t=0.624, 1.249, P=0.540, 0.228).The HDAC1 enzyme activity and HDAC1 level in TAC group were higher than those in SHAM group and TAC+LGSZ group (t=2.361~4.309, all P<0.05).The levels of GATA4 and Mef2c near Atp2a2 promoter region in TAC group were lower than those in TAC + LGSZ group (t=4.816, 5.007, all P<0.001).Conclusion  LGSZ up-regulates SERCA2a by regulating histone acetylation to prevent heart failure caused by pressure overload.

参考文献/References:

[1] ZIAEIAN B, FONAROW G C. Epidemiologyand aetiology of heart failure[J]. Nature ReviewsCardiology, 2016, 13(6): 368-378.
[2] RICH M W. Heart failure disease managementprograms: efficacy and limitations[J]. The AmericanJournal of Medicine, 2001, 110(5): 410-412.
[3] 贾昊,刘云鹏,屈欣怡,等.SERCA2a 在糖尿病心肌病中表达与调控研究进展[J]. 心肺血管病杂志,2018,37(2):165-168.JIA Hao, LIU Yunpeng, QU Xinyi, et al.The progressof SERCA2a expression and regulation in diabeticcardiomyopathy[J].Journal of Cardiovascular andPulmonary Diseases,2018,37(2):165-168.
[4] 吴锦波, 叶小汉, 冼绍祥, 等. 比索洛尔提高心力衰竭大鼠心肌SERCA2a 活性[J]. 基础医学与临床,2017,37(3):386-390.WU Jinbo,YE Xiaohan,XIAN Shaoxiang,et al.Bisoprolol increases myocardial SERCA2a activityin rats with heart failure[J]. Basic & ClinicalMedicine,2017,37(3):386-390.
[5] MATTILA M, KOSKENVUO J, S?DERSTR?M M, etal. Intramyocardial injection of SERCA2a-expressinglentivirus improves myocardial function in doxorubicininducedheart failure[J]. The Journal of Gene Medicine,2016, 18(7): 124-133.
[6] 屈慧,李娅,黄瑶楠,等.心力衰竭患者外周血RDW 和NT-pro-BNP 联合检测对临床诊断及分级的相关性研究[J].现代检验医学杂志,2020,35(5):65-67,72.QU Hui,LI Ya,HUANG Yaonan,et al. Correlationstudy on the combined detection of RDW and NT-Pro-BNP in patients with heart failure to clinical diagnosisand grading[J]. Journal of Modern LaboratoryMedicine,2020,35(5):65-67,72.
[7] ZHAI Yuting, LUO Yuanyuan, WU Pei, et al. Newinsights into SERCA2a gene therapy in heart failure:pay attention to the negative effects of B-typenatriuretic peptides[J]. Journal of Medical Genetics,2018, 55(5) : 287-296.
[8] SAKATA S, LEBECHE D, SAKATA N, et al.Restoration of mechanical and energetic function infailing aortic-banded rat hearts by gene transfer ofcalcium cycling proteins[J]. Journal of Molecular andCellular Cardiology, 2007, 42(4): 852-861.
[9] PIGNANI S, ZAPPATERRA F, BARBON E, etal. Tailoring the CRISPR system to transactivatecoagulation gene promoters in normal and mutatedcontexts[J]. Biochimica et Biophysica Acta-GeneRegulatory Mechanisms, 2019, 1862(6): 619-624.
[10] 马玉, 马先林. 川芎嗪对心血管的药理作用、临床应用及其效果分析[J]. 世界最新医学信息文摘,2019,19(30):213,219.MA Yu,MA Xianlin.Pharmacological action, clinicalapplication and effect analysis of Ligustrazine oncardiovascular system[J]. World Latest Medicine Information,2019,19(30):213,219.
[11] 季小勇.阿托伐他汀联合丹参川芎嗪治疗对冠心病伴高脂血症患者心功能及血脂的影响[J]. 血栓与止血学,2020,26(1):29-30,34.JI Xiaoyong. Effect of atorvastatin combined withDanshen and Ligustrazine on heart function andblood lipid in patients with coronary heart disease andhyperlipidemia [J]. Chinese Journal of Thrombosis andHemostasis,2020,26(1):29-30, 34.
[12] LIU Yanling, KONG Chunyan, SONG Peng, et al.Maslinic acid protects against pressure overloadinducedcardiac hypertrophy in mice[J]. Journal ofPharmacological Sciences, 2018, 138(2): 116-122.
[13] 全珺珺, 潘博, 贾忠莉, 等. 表没食子儿茶素没食子酸酯参与老年小鼠心脏SERCA2a 的调控及其机制[J]. 第三军医大学学报,2017,39(5):436-441.QUAN Junjun, PAN Bo, JIA Zhongli, et al. EGCGis involved in regulation of SERCA2a in agingmice hearts [J]. Journal of Third Military MedicalUniversity,2017,39(5):436-441.
[14] 浩日瓦, 娜日罕, 周红, 等. 血清microRNA126 和microRNA1 检测对心衰诊断价值的研究[J]. 现代检验医学杂志,2018,33(3):18-20,23.HAO Riwa,NA Rihan,ZHOU Hong,et al. Study on thediagnostic value of detecting serum microRNA126and microRNA1 in heart failure [J]. Journal of ModernLaboratory Medicine,2018,33(3):18-20,23.
[15] ALEXANIAN M, PADMANABHAN A, MCKINSEYT, et al. Epigenetic therapies in heart failure[J]. Journalof Molecular and Cellular Cardiology, 2019, 130: 197-204.
[16] 高婉琴, 李小丹, 杨朋康, 等. 血清Galectin-3 和sST2 水平检测用于保留射血分数心力衰竭的生物标记物的研究[J].现代检验医学杂志,2019,34(6):54-59.GAO Wanqin,LI Xiaodan,YANG Pengkang,et al.Study on Galectin-2 and sST2 used as biomarkerfor heart faliure patient with preserved ejectionfraction [J].Journal of Modern LaboratoryMedicine,2019,34(6):54-59.
[17] ZHAI Yuting, LUO Yuanyuan, WU Pei, et al. Newinsights into SERCA2a gene therapy in heart failure:pay attention to the negative effects of B-typenatriuretic peptides[J]. Journal of Medical Genetics,2018, 55(5): 287-296.
[18] 晏强, 周献青, 薛雯, 等. 表观遗传DNA 甲基化和组蛋白修饰与疾病关系的研究进展[J]. 医学综述,2017,23(16):3160-3163,3169.YAN Qiang,ZHOU Xianqing,XUE Wen,et al.Advances in the relationship between epigenetic DNAmethylation and histone modification with diseases[J].Medical Recapitulate,2017,23(16):3160-3163,3169.
[19] 张阳, 张志宇, 王辉, 等. 表观遗传学在心力衰竭中的最新研究进展[J]. 中国医学科学院学报, 2020, 42(1):103-107.ZHANG Yang,ZHANG Zhiyu,WANG Hui,et al.Recent advances of epigenetics in heart failure [J]. ActaAcademiae Medicinae Sinicae,2020,42(1):103-107.
[20] 张丽, 齐军, 吴宗勇, 等.耐碳青霉烯类肺炎克雷伯菌临床分离株中喹诺酮类及16SrRNA 甲基化酶基因的检测[J].现代检验医学杂志,2018,33(5):27-30.ZHANG Li,QI Jun,WU Zongyong,et al. Detectionof quinolone and 16SrRNA Methyltransferasegeneof clinical isolated carbapenem-resistant Klebsiellapneumoniae [J]. Journal of Modern LaboratoryMedicine, 2018,33(5):27-30.
[21] HELMSTADTER K G, LJUBOJEVIC-HOLZERS, WOOD B M, et al. CaMKII and PKA-dependentphosphorylation co-regulate nuclear localization ofHDAC4 in adult cardiomyocytes[J]. Basic Research inCardiology, 2021, 116(1): 11.

更新日期/Last Update: 1900-01-01